Clinical Radiology
Volume 65, Issue 7 , Pages 567-581 , July 2010

Molecular ultrasound imaging: current status and future directions

  • N. Deshpande

      Affiliations

    • Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California, USA
    • ,
  • A. Needles

      Affiliations

    • Visualsonics, Toronto, Canada
    • ,
  • J.K. Willmann

      Affiliations

    • Department of Radiology, Molecular Imaging Program at Stanford, Stanford University School of Medicine, Stanford, California, USA
    • Corresponding Author InformationGuarantor and correspondent: J. K. Willmann, Department of Radiology, Stanford University School of Medicine, 300 Pasteur Drive, Room H1307, Stanford, CA 94305-5105, USA. Tel.: +1 650 723 5424; fax: +1 650 723 1909.

Received 11 December 2009 ,Revised 19 February 2010 ,Accepted 25 February 2010.

References 

  1. Willmann JK, van Bruggen N, Dinkelborg LM, et al. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7(7):591–607
  2. Lanza GM, Wickline SA. Targeted ultrasonic contrast agents for molecular imaging and therapy. Curr Probl Cardiol. 2003;28(12):625
  3. Klibanov AL. Molecular imaging with targeted ultrasound contrast microbubbles. Ernst Schering Res Found Workshop. 2005;49:171
  4. McCulloch M, Gresser C, Moos S, et al. Ultrasound contrast physics: a series on contrast echocardiography, article 3. J Am Soc Echocardiogr. 2000;13(10):959
  5. Klibanov A, Gu H, Wojdyla JK, et-al. Attachemnet of ligands to gas filled microbubbles via PEG spacer and lipid residues anchored at the interface. 1999; Boston. p 124.
  6. Walday P, Tolleshaug H, Gjoen T, et al. Biodistributions of air-filled albumin microspheres in rats and pigs. Biochem J. 1994;299(Pt 2):437
  7. Willmann JK, Cheng Z, Davis C, et al. Targeted microbubbles for imaging tumour angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. Radiology. 2008;249(1):212
  8. Klibanov AL. Preparation of targeted microbubbles: ultrasound contrast agents for molecular imaging. Med Biol Eng Comput. 2009;
  9. Buchanan KD, Huang S, Kim H, et al. Echogenic liposome compositions for increased retention of ultrasound reflectivity at physiologic temperature. Journal of Pharmaceutical Sciences. 2007;97(6):2242
  10. Hamilton AJ, Huang SL, Warnick D, et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol. 2004;43(3):453
  11. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation. 1996;94(12):3334
  12. Lanza GM, Abendschein DR, Hall CS, et al. In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles. J Am Soc Echocardiogr. 2000;13(6):608
  13. Kripfgans OD, Fabiilli ML, Cardon PL, et al. On the acoustic vaporization of micrometer-sized droplets. J Acoust Soc Am. 2004;116(1):272
  14. Amirriazi S, Eghtedari M, Jin S, et-al. Increasing Ultrasound Sensitivity to Perfluorocarbon Emulsion Droplets 2009: Montreal Canada (abstract).
  15. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumour imaging and targeted chemotherapy. J Natl Cancer Inst. 2007;99(14):1095
  16. Maeda H, Wu J, Sawa T, et al. Tumour vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65(1–2):271
  17. Liu J, Levine AL, Mattoon JS, et al. Nanoparticles as image enhancing agents for ultrasonography. Phys Med Biol. 2006;51(9):2179
  18. Nolte I, Vince GH, Maurer M, et al. Iron particle enhance visualisation of experimental gliomas with high resolution sonography. Am J Neuroradiol. 2005;26:1469
  19. Linker RA, Kroner A, Horn T, et al. Iron particle-enhanced visualisation of inflammatory central nervous system lesions by high resolution: preliminary data in an animal model. AJNR Am J Neuroradiol. 2006;27(6):1225
  20. Lindner JR, Dayton PA, Coggins MP, et al. Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation. 2000;102:531
  21. Klibanov AL. Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem. 2005;16(1):9
  22. Marshall D, Pedley RB, Boden JA, et al. Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody. Br J Cancer. 1996;73(5):565
  23. Kaufmann BA. Ultrasound molecular imaging of atherosclerosis. Cardiovasc Res. 2009;
  24. Villanueva FS, Jankowski RJ, Klibanov S, et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation. 1998;98(1):1
  25. Alonso A, Della Martina A, Stroick M, et al. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke. 2007;38(5):1508
  26. Pochon S, Trady I, Bussat P, et al. PBR55: a lipopeptide-based KDR-targeted Ultrasound contrast agent for molecular imaging of angiogenesis. Investigative Radiology. 2010;45(2):89–95
  27. Pysz MA, Foygel K, Rosenberg J, et al. Antiangiogenic cancer therapy: Monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010); doi:10.1148/radiol.10091858.
  28. Becher H, Burns PN. Handbook of contrast echocardiography. Berlin: Springer; 2000;
  29. Leighton T. The acoustic bubble. Academic Press; 1997;
  30. de Jong N, Cornet R, Lancee CT. Higher harmonics of vibrating gas-filled microspheres. Part two: measurement. Ultrasonics. 1994;32:455
  31. Bouakaz A, Frigstad S, Ten Cate FJ, et al. Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound Med Biol. 2002;28(1):59
  32. Forsberg F, Shi WT, Goldberg BB. Subharmonic imaging of contrast agents. Ultrasonics. 2000;38:93
  33. Deng CX, Lizzi FL. A review of physical phenomena associated with ultrasonic contrast agents and illustrative clinical phenomena. Ultrasound Med Biol. 2002;28:277
  34. Hamilton M, Blackstock D. Nonlinear acoustics: theory and applications. Academic Press; 1998;
  35. Burns PN, Powers JE, Hope-Simpson D, et al. Harmonic power mode doppler using contrast agents: an improved method for small vessel flow imaging. J Ech Med Ultra. 1994;16:132
  36. Chang PH, Shung KK, Levine HB. Second harmonic imaging and harmonic doppler measurements with Albunex. IEEE Trans Ultrason Ferroelect Freq Contr. 1995;42:1020
  37. Hope-Simpson D, Chin CT, Burns PN. Pulse inversion doppler: a new method for detecting non-linear echoes from microbubble contrast agents. IEEE Trans Ultrason Ferroelect Freq Contr. 1999;46:372
  38. de Jong N, Frinking PJA, Buoakaz A, et al. Detection procedures of ultrasound contrast agents. Ultrasonics. 2000;38:87
  39. Haider B, Chiao RY. Higher order nonlinear ultrasonic imaging. Proc IEEE Ultrason Symp. 1999;2:1527
  40. Phillips PJ. Contrast pulse sequences (CPS): imaging nonlinear microbubbles. Proc IEEE Ultrason Symp. 2001;2:1739
  41. Eckersley RJ, Chin CT, Burns PN. Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultra Med Biol. 2005;31:213
  42. Averkiou MA. Tissue harmonic ultrasonic imaging. CR Acad Sci Ser IV-Phys Astrophys. 2001;2:1139–1151
  43. Hope-Simpson D, Burns PN, Averkiou MA. Techniques for perfusion imaging with microbubble contrast agents. IEEE Trans Ultrason Ferroelect Freq Contr. 2001;48:1483
  44. Foster FS, Pavlin CJ, Harasiewicz KA, et al. Advances in ultrasound biomicroscopy. Ultrasound Med Biol. 2000;26:1
  45. Foster FS, Zhang MY, Zhou YQ, et al. A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med Biol. 2002;28(9):1165
  46. Needles A, Goertz DE, Karshafian R, et al. High-frequency subharmonic pulsed-wave Doppler and colour flow imaging of microbubble contrast agents. Ultrasound Med Biol. 2008;34:1139
  47. Goertz DE, Cherin E, Needles A, et al. High frequency nonlinear B-Scan imaging of microbubble contrast agents. Ultrason Ferroelectr Freq Cont. 2005;52:65
  48. Rychak JJ, Graba J, Cheung AM, et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumour angiogenesis. Mol Imaging. 2007;6(5):289
  49. Lyshchik A, Fleischer AC, Huamani J, et al. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med. 2007;26(11):1575
  50. Willmann JK, Paulmurugan R, Chen K, et al. US imaging of tumour angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology. 2008;246(2):508
  51. Vassiliadis S, Hakkennes EA, Wong JSSM, et al. The sum-absolute-difference motion estimation accelerator. Proc IEEE Euromicro Conference. 1998;2:559–566
  52. Ritter TA, Shrout TR, Tutweiler R, et-al. A 30 MHz peizo-composite ultrasound array for medical imaging applications. 2002;49:217.
  53. Lukacs M, Yin J, Pang G, et al. Performance and characterization of new micromachined high-frequency linear arrays. IEEE Trans Ultrason Ferroelec Freq Contr. 2006;53:1719
  54. Brown JA, Foster FS, Needles A, et al. Fabrication and performance of a 40-MHz linear array based on a 1–3 composite with geometric elevation focusing. IEEE Trans Ultrason Ferroelectr Freq Cont. 2007;54:1888–1894
  55. Foster FS, Mehi J, Lukacs M, et al. A new 15–50 MHz array-based micro-ultrasound scanner for preclinical imaging. Ultrasound Med Biol. 2009;35(10):1700
  56. Needles A, Coulthard T, Mehi J, et-al. Nonlinear Molecular Imaging with a Linear Array Based Micro-Ultrasound System. 2009; Montreal, Canada (abstract).
  57. de Jong N, Hoff L. Ultrasound scattering properties of Albunex microspheres. Ultrasonics. 1993;31:175
  58. Rognin NG, Frinking P, Costa M, et al. In-vivo perfusion quantification by contrast ultrasound: validation of the use of linearized video data vs. raw RF data. Proc IEEE Ultrason Symp. 2008;1:1690
  59. Arditi M, Frinking PJ, Zhou X, et al. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2006;53(6):1118
  60. Folkman J. Angiogenesis. Annu Rev Med. 2006;57:1
  61. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57
  62. Lee DJ, Lyshchik A, Huamani J, et al. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. J Ultrasound Med. 2008;27:855
  63. Willmann JK, Lutz AM, Paulmurugan R, et al. Dual-targeted contrast agent for US assessment of tumour angiogenesis in vivo. Radiology. 2008;248(3):936
  64. Korpanty G, Carbon JG, Grayburn PA, et al. Monitoring response to anticancer therapy by targeting microbubbles to tumour vasculature. Clin Cancer Res. 2007;13(1):323
  65. Palmowski M, Huppert J, Ladewig G, et al. Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects. Mol Cancer Ther. 2008;7(1):101
  66. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol. 2003;3(10):822
  67. Lindner JR, Song J, Xu F, et al. Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes. Circulation. 2000;102(22):2745
  68. Ferrante EA, Pickard JE, Rychak J, et al. Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release. 2009;140(2):100
  69. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104(17):2107
  70. Kaufmann BA, Lewis C, Xie A, et al. Detection of recent myocardial ischaemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J. 2007;28(16):2011
  71. Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116(3):276
  72. Bachmann C, Klibanov AL, Olson TS, et al. Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn’s disease. Gastroenterology. 2006;130(1):8
  73. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischaemic memory imaging with molecular echocardiography. Circulation. 2007;115(3):345
  74. Schumann PA, Christiansen JP, Quigley RM, et al. Targeted-microbubble binding selectively to GPIIb IIIa receptors of platelet thrombi. Invest Radiol. 2002;37(11):587
  75. Wang B, Zang WJ, Wang M, et al. Prolonging the ultrasound signal enhancement from thrombi using targeted microbubbles based on sulfur-hexafluoride-filled gas. Acad Radiol. 2006;13(4):428
  76. Chérin E, Brown J, Mâsøy SE, et al. Radial modulation imaging of microbubble contrast agents at high frequency. Ultrasound Med Biol. 2008;34(6):949
  77. Bouakaz A, Versluis M, Borsboom J, et al. Radial modulation of microbubbles for ultrasound contrast imaging. IEEE Trans Ultrason Ferroelectr Freq Control. 2007;54(11):2283
  78. Chérin E, Brown J, Måsøy S, et al. Radial modulation imaging of microbubble contrast agents at high frequency. Ultrasound Med Biol. 2008;34:949
  79. Måsøy SE, Standa O, Näsholm P, et al. SURF Imaging: in vivo demonstration of an ultrasound contrast agent detection technique. IEEE Trans Ultrason Ferroelec Freq Contr. 2008;55:1112
  80. Måsøy SE, Hansen R, Angelsen A, et al. SURF Imaging – High-frequency ultrasound contrast agent imaging in patients with prostate cancer. 2008; Rotterdam, The Netherlands, (abstract).
  81. Måsøy SE, Deibele JM, Tangen TA, et al. SURF imaging – A real time dual-frequency band ultrasound system. Proc IEEE Ultrason Symp. 2009;
  82. Goertz DE, de Jong N, van der Steen AF. Attenuation and size distribution measurements of definity and manipulated definity populations. Ultrasound Med Biol. 2007;33:1376
  83. Willmann JK, Kimura RH, Deshpande N, et al. Novel integrin-binding ultrasound contrast agent for molecular ultrasound imaging of tumour angiogenesis. J of Nuclear Medicine J Nucl Med. 2010;51(3):433
  84. Zhao S, Kruse DE, Ferrara KW, et al. Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol. 2007;52(8):2055
  85. Frinking P, Tardy I, Theraulaz M, et al. The effect of radiation force on binding efficiency and specificity of target-specific contrast-agent microbubbles. Proc IEEE Ultrason Symp; In press.
  86. Gessner R, Lee M, Lukacs M, et al. Radiation force-enhanced targeted imaging using a dual-frequency high-resolution transducer. Proc IEEE Ultrason Symp In press.
  87. Tardy I, Frinking P, Theraulaz M, et al. Ultrasound radiation force application to KDR-targeted contrast agent in tumour angiogenesis model. Montreal, Canada 2009 (abstract).
  88. Couture O, Bannouf S, Montaldo G, et al. Ultrafast imaging of ultrasound contrast agents. Ultrasound Med Biol. 2009;35(11):1908
  89. Needles A, Couture O, Foster FS. A method for differentiating targeted microbubbles in real time using subharmonic micro-ultrasound and interframe filtering. Ultrasound Med Biol. 2009;35:1564
  90. Benacerraf BR, Benson CB, Abuhamad AZ, et al. Three- and 4-dimensional ultrasound in obstetrics and gynecology: proceedings of the American Institute of Ultrasound in Medicine Consensus Conference. J Ultrasound Med. 2005;24(12):1587
  91. Piscaglia F, Bolondi L. The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32(9):1369
  92. Blomley M, Claudon M, Cosgrove D. WFUMB Safety symposium on ultrasound contrast agents: clinical applications and safety concerns. Ultrasound Med Biol. 2007;33(2):180
  93. FDA. Micro-bubble Contrast Agents (marketed as Definity (Perflutren Lipid Microsphere) Injectable Suspension and Optison (Perflutren Protein-Type A Microspheres for Injection). 2008.
  94. Kusnetzky LL, Khalid A, Khumri TM, et al. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. Journal of the American College of Cardiology. 2008;51(17):1704
  95. Mehdiratta R, Saberwal G. Bio-business in brief: many a monoclonal. Current Science. 2007;93(6):789

PII: S0009-9260(10)00125-X

doi: 10.1016/j.crad.2010.02.013

Clinical Radiology
Volume 65, Issue 7 , Pages 567-581 , July 2010

Article Tools

* Image Usage & Resolution